{"prompt": "['Glick HAD, Sonnad, S.S., Polsky, D.: Analyzing Censored cost. In: Economic Evaluation in', 'Clinical Trials. Glick HA (ed.) Oxford, New York, NY, pp 123-139,2015.', 'GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.', '2012 [cited 2014 Aug 12]; Available from: http://globocan.iarc.fr/Default.aspx', 'Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA,', 'Zelefsky MJ. Long-term outcomes after high-dose postprostatectomy salvage radiation', 'treatment. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):112-8.', 'Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk.', 'Ann Stat 1988;16:1141-1154', 'Hall, E.J. and A.J. Giaccia, Radiobiology for the Radiologist2012 Wolters Kluwer Health.', 'Hamilton, A.S., et al., Trends in the treatment of localized prostate cancer using supplemented', 'cancer registry data. BJU Int, 2011. 107(4): p. 576-84.', 'Harrison, A., et al., Potential for dose escalation in the post-prostatectomy setting with intensity-', 'modulated radiation therapy: a dosimetric study using EORTO consensus guidelines for', 'target volume contours. Practical Radiation Oncology, 2011. 1(2): p. 105-114.', 'Hoffman, K.E., et al., Recommendations for post-prostatectomy radiation therapy in the United', 'States before and after the presentation of randomized trials. J Urol, 2011. 185(1): p.', '116-20.', 'Hunter, G.K., et al., Late toxicity after intensity modulated and image guided radiation therapy', 'for localized prostate cancer and post-prostatectomy patients. Practical Radiation', 'Oncology, 2012.', 'Kaplan EL, Meier P. Non-parameteric estimation from incomplete observations. Journal', 'American Statistical Association 1958;53:457-481.', 'Konski A, Sherman E, Krahn M, et al.: Economic analysis of a phase III clinical trial evaluating', 'the addition of total androgen suppression to radiation versus radiation alone for locally', 'advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10). Int J', 'Radiat Oncol Biol Phys 63: 788-794, 2005.', 'Konski A, Speier W, Hanlon A, Beck JR and Pollack A: Is proton beam therapy cost effective in', 'the treatment of adenocarcinoma of the prostate? J Clin Oncol 25: 3603-3608, 2007.', 'Konski A, Watkins-Bruner D, Brereton H, Feigenberg S and Hanks G: Long-term hormone', 'therapy and radiation is cost-effective for patients with locally advanced prostate', 'carcinoma. Cancer 106: 51-57, 2006.', 'Konski A, Watkins-Bruner D, Feigenberg S, et al.: Using decision analysis to determine the cost-', 'effectiveness of intensity-modulated radiation therapy in the treatment of intermediate', 'risk prostate cancer. Int J Radiat Oncol Biol Phys 66: 408-415, 2006.', 'NRG-GU003', '51', 'Version Date: April 26, 2019']['Kruser, T.J., et al., Early hypofractionated salvage radiotherapy for post-prostatectomy', 'biochemical recurrence. Cancer, 2011. 117(12): p. 2629-36.', 'Kuban, D., A. El-Mahdi, and P. Schellhammer, I-125 interstitial implantation for prostate', 'cancer. Cancer, 1989. 63: p. 2415-2420.', 'Kuban, D.A., A.M. el-Mahdi, and P.F. Schellhammer, Effect of local tumor control on distant', 'metastasis and survival in prostatic adenocarcinoma. Urology, 1987.30(5) p. 420-6.', 'Kuban, D.A., et al., Long-term failure patterns and survival in a randomized dose-escalation', 'trial for prostate cancer. Who dies of disease? int J Radiat Oncol Biol Phys, 2011.79(5)', 'p. 1310-7.', 'Kuban, D.A., et al., Long-term results of the M. D. Anderson randomized dose-escalation trial', 'for prostate cancer. Int J Radiat Oncol Biol Phys, 2008. 70(1): p. 67-74.', 'Kupelian, P.A., et al., Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 gy per', 'fraction) for localized prostate cancer: cleveland clinic experience. Int J Radiat Oncol', 'Biol Phys, 2007. 68(5): p. 1424-30.', 'Kupelian, P.A., et al., Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per', 'fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol', 'Phys, 2005. 63(5): p. 1463-8.', 'Lan, K. and E. DeMets, Discrete sequential boundaries for clinical trials. Biometrika, 1983. 70:', 'p. 659-663.', 'Lawton CA, Bae K, Pilepich M, Hanks G, Shipley W. Long-term treatment sequelae after', 'external beam irradiation with or without hormonal manipulation for adenocarcinoma of', 'the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-', '02. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):437-41. Epub 2007 Sep 19.', 'Leborgne, F., et al., Later outcomes and alpha/beta estimate from hypofractionated conformal', 'three-dimensional radiotherapy versus standard fractionation for localized prostate', 'cancer. int J Radiat Oncol Biol Phys, 2012. 82(3): p. 1200-7.', 'Lee WR, Dignam JJ, Amin M, et al. NRG Oncology RTOG 0415: A randomized phase 3', 'noninferiority study comparing 2 fractionation schedules in patients with low-risk', 'prostate cancer. Int J Radiat Oncol Biol Phys. Volume 94, Issue 1, 1 January 2016,', 'pages 3-4.', 'Little RA. Modeling the Drop-out Mechanism in Repeated-Measures Studies. J Am Stat Assoc.', '1995;90(431):1112-1121.', 'Mantel N. Evaluation of survival data and two new rank order statistics arising in its', 'consideration. Cancer Chemother Rep 1966;50:163-170.', \"O'Brien, P.C. and T.R. Fleming, A multiple testing procedure for clinical trials. Biometrics,\", 'NRG-GU003', '52', 'Version Date: April 26, 2019']\n\n###\n\n", "completion": "END"}